文献速递肿瘤 PET/CT骨显像与常规 SPECT

肩部弥漫型腱鞘巨细胞瘤的FDG PET/CT评估

Diffuse-Type Tenosynovial Giant Cell Tumor of the Shoulder Evaluated by FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2019-01-01

一例74岁女性右肩无痛性肿块,FDG PET/CT显示病灶SUVmax 19.2,术后病理证实为弥漫型腱鞘巨细胞瘤;术后3年随访PET/CT发现更广泛的软组织浸润和邻近骨侵蚀。FDG PET/CT良好展示了该病灶的高代谢和局部侵袭性特征。

要点

  • 肩部弥漫型腱鞘巨细胞瘤罕见,FDG PET/CT可显示高代谢(SUVmax 19.2)。
  • 术后3年随访PET/CT可发现更广泛软组织浸润和骨侵蚀。
  • FDG PET/CT有助于展示该肿瘤的高代谢和局部侵袭性。

核心结论

  • FDG PET/CT良好展示了肩部弥漫型腱鞘巨细胞瘤的高代谢和局部侵袭性特征。

研究设计与样本

  • 本文为单病例报告,描述一例74岁女性右肩无痛性肿块的FDG PET/CT评估及术后随访。

主要发现

  • FDG PET/CT显示病灶FDG摄取强烈,SUVmax为19.2。
  • 术后病理证实为弥漫型腱鞘巨细胞瘤。
  • 术后3年随访FDG PET/CT显示更广泛的软组织浸润和邻近骨侵蚀。

临床怎么用

  • 对肩部罕见弥漫型腱鞘巨细胞瘤,FDG PET/CT可用于展示高代谢和局部侵袭性,并可用于术后随访评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diffuse-type tenosynovial giant cell tumor is a locally aggressive neoplasm that typically involves the knee and hip but rarely involves the shoulder. In this case, a 74-year-old woman presented a painless mass in the right shoulder. FDG PET/CT demonstrated intense FDG uptake with an SUVmax of 19.2 in the lesion. The mass was dissected and confirmed as diffuse-type tenosynovial giant cell tumor by pathology. Follow-up FDG PET/CT assessment revealed more extensive soft tissue infiltration and adjacent bone erosion 3 years after surgery. Thus, FDG PET/CT well demonstrated the hypermetabolic and local aggressive characteristics of the lesion.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Tang K, Zheng X, Lin J, et al. Diffuse-Type Tenosynovial Giant Cell Tumor of the Shoulder Evaluated by FDG PET/CT. Clin Nucl Med. 2019. PMID: 30624274. doi:10.1097/RLU.0000000000002451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。